As a key component of SCF (Skp1–cullin–F-box proteins) E3 ubiquitin ligase, SAG is recently recognized as an anticancer agent in a pancreatic cancer system in vivo.13 However, the detailed molecular mechanism of action of SAG in cancer progression is hitherto unknown. Here, KITLG is linked to familial pancreatic carcinoma.